It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Ascorbic acid (AA) may contribute to restoring hemostatic balance after mental stress (MS) in overweight/obese adults. We aimed to determine the effects of AA administration on hemostatic responses to MS in overweight/obese men. Fourteen overweight/obesity men (27 ± 7 years; BMI: 29.7 ± 2.6 kg m−2) performed the Stroop color-word stress task for 5 min after non-simultaneous infusion of placebo (PL, 0.9% NaCl) and AA (3 g). Blood was collected at baseline, during MS, and 60 min after MS to measure: activated partial thromboplastin time, prothrombin time, and fibrinogen concentration, by coagulometer; platelet-derived microvesicles (PMV, mv/μL), by flow cytometry; nitrite (μM), by chemiluminescence. In PL session, MS led to decreases in PTs (stress, p = 0.03; 60 min, p < 0.001), PT-INR (stress, p < 0.001; 60 min, p < 0.01), aPTTs (60 min, p = 0.03), aPTT ratio (60 min, p = 0.04) and fibrinogen (60 min, p = 0.04), while increased PT activity (60 min, p = 0.01) when compared to baseline. Furthermore, AA increased PTs (60 min, p < 0.001), PT-INR (60 min, p = 0.03) and decreased PT activity (60 min, p < 0.001) and fibrinogen (stress, p = 0.04) when compared to PL. Nitrite was increased in response to stress during AA session (p < 0.001 vs PL). There was no difference in PMV. Ascorbic acid prevented the impaired hemostatic profile and improved nitrite response to stress in the overweight and obese adults.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Fluminense Federal University, Laboratory of Exercise Sciences, Department of Physiology and Pharmacology, Niterói, Brazil (GRID:grid.411173.1) (ISNI:0000 0001 2184 6919); Fluminense Federal University, Laboratory of Integrative Cardiometabology, Department of Physiology and Pharmacology, Niterói, Brazil (GRID:grid.411173.1) (ISNI:0000 0001 2184 6919); National Council for Scientific and Technological Development (CNPq), National Institute of Science and Technology (INCT) - Physical (In)Activity and Exercise, Niterói, Brazil (GRID:grid.450640.3) (ISNI:0000 0001 2189 2026)
2 Fluminense Federal University, Laboratory of Exercise Sciences, Department of Physiology and Pharmacology, Niterói, Brazil (GRID:grid.411173.1) (ISNI:0000 0001 2184 6919); Fluminense Federal University, Laboratory of Integrative Cardiometabology, Department of Physiology and Pharmacology, Niterói, Brazil (GRID:grid.411173.1) (ISNI:0000 0001 2184 6919)